IP Library Patent Application 18940096
Patent Application
App. No. 18/940,096

METHOD AND SYSTEM FOR THE DETECTION OF CEREBRAL AMYLOID ANGIOPATHY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/940,096
Abstract

A method and system detects cerebral amyloid angiopathy (CAA) condition of a subject by capturing multiple images of the subject's retina, processing the images to detect any retinal hemorrhage, retinal vessel tortuosity, and retinal edema, to predict the likelihood of CAA.

Claims (58)

1 . A method for detecting cerebral amyloid angiopathy (CAA) in a subject, comprising:

capturing multiple autofluorescence images of the subject's retina;

analyzing the images to detect and quantify perivascular amyloid accumulation along retinal blood vessels; and

determining a likelihood of CAA based on the detected perivascular amyloid accumulation.

2 . The method of claim 1 , further comprising:

creating a standardized region of interest using a registration function and detection of optic nerve head and fovea.

3 . The method of claim 1 , further comprising:

applying an image quality filter to eliminate low quality images.

4 . The method of claim 1 , further comprising:

detecting retinal hemorrhage and vessel tortuosity.

5 . The method of claim 1 , further comprising:

detecting retinal edema using optical coherence tomography (OCT).

6 . A method for detecting a cerebral amyloid angiopathy (CAA) condition of a subject, comprising:

i. capturing multiple images of a retina of the subject;

ii. creating a standardized region of interest of the multiple images using a registration function, image quality assessment, and detection of optic nerve head (ONH) and fovea;

iii. applying an image filter and blink detector to eliminate images that are of low image quality;

iv. performing background correction on the images;

V. applying a vessel detection algorithm on the images;

vi. applying a probability density function (PDF) fit of the retina and segmentation of retinal auto fluorescence;

vii detecting any retinal hemorrhage and retinal vessel tortuosity;

viii. detecting any retinal edema by optical coherence tomography (OCT)

ix. using individual elements and a combined data vector to predict the likelihood of CAA of the subject.

7 . The method of claim 6 , further including using the individual elements and combined data vector to predict the likelihood of Amyloid Related Imaging Abnormalities (ARIA-E and ARIA-H).

8 . The method of claim 6 , wherein the capturing multiple images of a retina captures images in blue auto fluorescence (AF), green AF, color, infrared (IR), and OCT.

9 . The method of claim 6 , wherein the step of applying an image filter and blink detector eliminates images of low image quality due to cataracts and lid obstructions.

10 . The method of claim 6 , wherein the steps a-h are performed in a camera which captures multiple images.

11 . The method of claim 6 , wherein step a is performed using an Optos wide field retinal imaging device.

12 . The method of claim 6 , further including the step of quantifying amyloid along blood vessels.

13 . The method of claim 6 , wherein step a is performed using a Center Vue Eidon or Heidelberg Spectralis device.

14 . A system for detecting cerebral amyloid angiopathy (CAA) in a subject, comprising:

An image capture device for capturing multiple autofluorescence images of the subject's retina;

A processor for analyzing the images to detect and quantify perivascular amyloid accumulation along retinal blood vessels, and determining a likelihood of CAA based on the detected perivascular amyloid accumulation.

15 . The system of claim 14 , wherein the processor:

creates a standardized region of interest using a registration function and detection of optic nerve head and fovea.

16 . The system of claim 14 , further comprising:

an image quality filter to eliminate low quality images.

17 . The system of claim 14 , wherein the processor:

detects retinal hemorrhage and vessel tortuosity.

18 . The system of claim 14 , wherein the processor:

detects retinal edema using optical coherence tomography (OCT).

19 . A system for detecting a cerebral amyloid angiopathy (CAA) condition of a subject, comprising:

an image capture device to capture multiple images of a retina of the subject;

a processor for:

i. creating a standardized region of interest of the multiple images using a registration function, image quality assessment, and detection of optic nerve head (ONH) and fovea;

ii. filtering the images and detecting blink to eliminate images that are of low image quality;

iii. performing background correction on the images;

iv. applying a vessel detection algorithm on the images;

v. applying a probability density function (PDF) fit of the retina and segmentation of retinal auto fluorescence; and

vi. detecting any retinal hemorrhage and retinal vessel tortuosity; and

an optical coherence tomography (OCT) device for detecting any retinal edema; and

wherein the processor uses individual elements and a combined data vector to predict the likelihood of CAA of the subject.

20 . The system of claim 19 , wherein the processor uses individual elements and combined data vector to predict the likelihood of Amyloid Related Imaging Abnormalities (ARIA-E and ARIA-H).

21 . The system of claim 19 , wherein the image capture device captures multiple images of a retina captures images in blue auto fluorescence (AF), green AF, color, infrared (IR), and OCT.

22 . The system of claim 19 , wherein the processor eliminates images of low image quality due to cataracts and lid obstructions.

23 . The system of claim 19 , wherein the processor is part of a camera which captures multiple images.

24 . The system of claim 19 , wherein the image capture device is an Optos wide field retinal imaging device.

25 . The system of claim 19 , wherein the processor quantifies amyloid along blood vessels.

26 . The system of claim 19 , wherein the image capture device is a Center Vue Eidon or Heidelberg Spectralis device.

Assignments (1)
SECURITY INTEREST Recorded Dec 10, 2025
From: NEUROVISION IMAGING, INC.; FUTUREHEALTH SERVICES, LLC
To: WILDCAT PARTNER HOLDINGS, LP
Reel/Frame 073179/0485 →